Compounds > moxifloxacin
Page last updated: 2024-09-04

moxifloxacin and amphotericin b

moxifloxacin has been researched along with amphotericin b in 9 studies

Compound Research Comparison

Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010)
(moxifloxacin)		Studies
(amphotericin b)		Trials
(amphotericin b)		Recent Studies (post-2010) (amphotericin b)
3,1575521,69017,2106734,294

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's7 (77.78)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolivette, LJ; Ward, KW1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Andreo, EG; Arcieri, ES; Arcieri, RS; Finotti, IG; Furlanetto, RL; Mendonça, CN; Rizzo, LV; Rocha, A; Rocha, FJ1
Akyürek, N; Deren, YT; Hasanreisoğlu, B; Kalkanci, A; Ozdek, S1
Fidan, I; Gürelik, F; Kalkanci, A; Kustimur, S; Ozdek, S; Yalçin, B1
Arnalich-Montiel, F; López-Arencibia, A; Lorenzo-Morales, J; Martín-Navarro, CM; Piñero, JE; Valladares, B1
Brothers, KM; Dhaliwal, DK; Hunt, KM; Nau, AC; Romanowski, EG; Shanks, RM; Zambelli, AM1

Reviews

1 review(s) available for moxifloxacin and amphotericin b

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for moxifloxacin and amphotericin b

ArticleYear
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
    Journal of pharmaceutical sciences, 2005, Volume: 94, Issue:7

    Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution

2005
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
Infectious keratitis secondary to Histoplasma capsulatum: the first case reports in humans.
    The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2007, Volume: 11, Issue:6

    Topics: Adult; Amphotericin B; Antifungal Agents; Aza Compounds; Eye Infections, Fungal; Fluoroquinolones; Histoplasma; Humans; Keratitis; Male; Moxifloxacin; Quinolines

2007
Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
    Canadian journal of microbiology, 2010, Volume: 56, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Aza Compounds; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Fungal; Drug Therapy, Combination; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Infections, Fungal; Fluoroquinolones; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Vitreous Body

2010
[In vitro synergistic effect of moxifloxacin and amphotericin B combination against Candida strains].
    Mikrobiyoloji bulteni, 2010, Volume: 44, Issue:1

    Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Aza Compounds; Candida; Candidiasis; Drug Synergism; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines

2010
Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:9

    Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Aza Compounds; Chlorhexidine; Colorimetry; Drug Combinations; Fluoroquinolones; HeLa Cells; Humans; Macrophages; Mice; Moxifloxacin; Ophthalmic Solutions; Parasitic Sensitivity Tests; Pyrimidines; Quinolines; Triazoles; Voriconazole

2013
Diffusion of Antimicrobials Across Silicone Hydrogel Contact Lenses.
    Eye & contact lens, 2015, Volume: 41, Issue:5

    Topics: Amphotericin B; Anti-Infective Agents; Biguanides; Colony Count, Microbial; Contact Lenses, Hydrophilic; Diffusion; Fluoroquinolones; Hydrogel, Polyethylene Glycol Dimethacrylate; Moxifloxacin; Saccharomyces cerevisiae; Silicones; Spectrophotometry; Staphylococcus epidermidis

2015